Clrb stock price target
Get breaking news and analysis on Cellectar Biosciences, Inc. (CLRB) stock, price quote and chart, trading and investing tools. Cellectar Biosciences Inc. (CLRB) Stock Message Board ... Mar 16, 2020 · Our proprietary phospholipid ether (PLE) platform technology features include the capacity to link to a wide variety of warheads, provide a significant increase in targeted oncologic warhead delivery and the ability to target all tumor cells. CLRB - Cellectar Biosciences Inc Stock quote - CNNMoney.com Find real-time CLRB - Cellectar Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. CLRB - Cellectar Biosciences Inc Stock quote - CNNMoney.com Markets
Get the latest Cellectar Biosciences, Inc. (CLRB) stock news and headlines to help you in your trading and investing decisions. 1y Target Est: N/A: Fair Value is the appropriate price for the
Stock Information. March 23, 2020 3:59 PM EDT. Symbol. Nasdaq: CLRB to develop PDCs that specifically target cancer cells to deliver improved efficacy and 21 Jan 2020 Capital analyst Jonathan Aschoff assumes primary coverage on Cellectar Biosciences (NASDAQ: CLRB) with a Buy rating and a price target Company Name: Cellectar Biosciences Inc., Stock Symbol: CLRB, Industry: in targeted oncologic warhead delivery and the ability to target all tumor cells. 13 Sep 2019 Roth Capital Partners launched coverage of Cellectar Biosciences (NASDAQ: CLRB) with a “buy” rating and $11 price target. The stock closed
Cellectar Biosciences (NASDAQ:CLRB) Stock Rating ...
Their average twelve-month price target is $6.33, suggesting that the stock has a possible upside of 369.14%. The high price target for CLRB is $10.00 and the Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research Cellectar Biosciences, Inc quote is equal to 1.190 USD at 2020-04-07. Based on our forecasts, a long-term increase is expected, the "CLRB" stock price prognosis Cellectar Biosciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CLRB updated stock price target summary. Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital NasdaqCM - NasdaqCM Real Time Price. 1y Target Est, 6.35 Real-time trade and investing ideas on Cellectar Biosciences, Inc. CLRB from the largest community of traders and investors.
CLRB | Complete Cellectar Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Our core objective is to leverage our proprietary phospholipid drug conjugates™ (PDCs™) delivery platform to develop PDCs that specifically target cancer cells to deliver improved efficacy and better safety as a result of fewer off-target effects. CLRB - Research and Analysis for CELLECTAR BIOSCIENCES ... In-depth view of key statistics and finances for CELLECTAR BIOSCIENCES, INC. (CLRB) on MSN Money.
Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital NasdaqCM - NasdaqCM Real Time Price. 1y Target Est, 6.35
Split History. Stock splits are used by Cellectar Biosciences, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a
Jan 01, 2010 · Cellectar Biosciences (Nasdaq: CLRB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers